CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-12 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 249,910 | ||
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,289 | $569.46 | $734K | 27,587 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,059 | $570.17 | $1.2M | 25,528 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,496 | $571.42 | $855K | 24,032 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,356 | $572.32 | $776K | 22,676 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −480 | $573.22 | $275K | 22,196 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −661 | $574.57 | $380K | 21,535 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −530 | $575.26 | $305K | 21,005 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −89 | $576.68 | $51K | 20,916 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −893 | $577.59 | $516K | 20,023 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −476 | $578.42 | $275K | 19,547 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −591 | $579.80 | $343K | 18,956 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −80 | $580.45 | $46K | 18,876 |
| 2026-05-11 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 12,500 | ||
| 2026-05-11 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-05-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,165 | $569.50 | $663K | 48,848 |
| 2026-05-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,019 | $570.21 | $1.2M | 46,829 |
| 2026-05-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,356 | $571.43 | $775K | 45,473 |
| 2026-05-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,292 | $572.39 | $740K | 44,181 |
Page 105 of 121 · 2,404 trades